Le, X., Patel, J. D., Shum, E., Baik, C., Sanborn, R. E., Shu, C. A., Kim, C., Fidler, M. J., Hall, R., Elamin, Y. Y., Tu, J., Blumenschein, G., Zhang, J., Gibbons, D., Gay, C., Mohindra, N. A., Chae, Y., Boumber, Y., Sabari, J., … Heymach, J. V. (2024). A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve EGFR-Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial). Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00533
Publication Type:
Article
Unique ID:
10.1200/jco.24.00533
PMID:
DOI:
Journal:
Publication Date:
Data Source:
PubMed